col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: American Society for Pharmacology & Experimental Therapeutics

18 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] Journal of Pharmacology and Experimental Therapeutics 2022―Jul―03 Cardiovascular implications of miRNAs in COVID-19 Carmine Izzo, Valeria Visco, Jessica Gambardella, Germano Junior Ferruzzi, Antonella Rispoli, Maria Rosaria Rusciano, et al. (+7)
2 [GO] Journal of Pharmacology and Experimental Therapeutics 2022―Jun―30 Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19 Jessica Gambardella, Urna Kansakar, Celestino Sardu, Vincenzo Messina, Stanislovas S. Jankauskas, Raffaele Marfella, et al. (+6)
3 [GO] Journal of Pharmacology and Experimental Therapeutics 2022―Mar―26 L-Arginine Enhances the Effects of Cardiac Rehabilitation on Physical Performance: New Insights for Managing Cardiovascular Patients During the COVID-19 Pandemic Pasquale Mone, Raffaele Izzo, Giuseppe Marazzi, Maria Virginia Manzi, Paola Gallo, Giuseppe Campolongo, et al. (+6)
4 [GO] Drug Metabolism and Disposition 2022―Feb―13 Disposition of PF-07321332 (Nirmatrelvir), an Orally Bioavailable Inhibitor of SARS-CoV-2 3CL Protease, across Animals and Humans Heather Eng, Alyssa L Dantonio, Eugene P Kadar, R. Scott Obach, Li Di, Jian Lin, et al. (+7)
5 [GO] Molecular Pharmacology 2022―Feb―01 A Comment on “Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites” Eric K. Johnson
6 [GO] Molecular Pharmacology 2022―Feb―01 Response to Comments on “Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites” Siennah R. Miller, Meghan E. McGrath, Kimberley M. Zorn, Sean Ekins, Stephen H. Wright, Nathan J. Cherrington
7 [GO] Pharmacological Reviews 2022―Jan―31 Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines Simone Pecetta, Sven Kratochvil, Yu Kato, Kumaran Vadivelu, Rino Rappuoli, Qiang Ma
8 [GO] Molecular Pharmacology 2021―Sep―09 Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites Siennah R. Miller, Meghan E. McGrath, Kimberley M. Zorn, Sean Ekins, Stephen H. Wright, Nathan J. CHERRINGTON
9 [GO] Journal of Pharmacology and Experimental Therapeutics 2021―Jul―12 Cationic Compounds with SARS-CoV-2 Antiviral Activity and their Interaction with OCT/MATE Secretory Transporters. Lucy Jazmin Martinez Guerrero, Xiaohong Zhang, Kimberley M. Zorn, Sean Ekins, Stephen H. Wright
10 [GO] Journal of Pharmacology and Experimental Therapeutics 2021―May―10 Viral Proteases as Targets for COVID-19 Drug Development Wei Zhu, Zeenat A Shyr, Donald C. Lo, Wei Zheng
11 [GO] Pharmacological Reviews 2021―Mar―09 Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics Peter Garred, Andrea J. Tenner, Tom E. Mollnes, Finn Olav Levy
12 [GO] Journal of Pharmacology and Experimental Therapeutics 2021―Mar―05 COVID-19 drugs chloroquine and hydroxychloroquine, but not azithromycin and remdesivir, block hERG potassium channels Mark Szendrey, Jun Guo, Wentao Li, Tonghua Yang, Shetuan Zhang
13 [GO] Journal of Pharmacology and Experimental Therapeutics 2020―Oct―28 A Biomarker-Centric Approach to Drug Discovery and Development: Lessons Learned from the COVID-19 Pandemic Kelly A. Fader, Jiangwei Zhang, Joseph P. Menetski, Ravi I. Thadhani, Elliott M. Antman, Gary S. Friedman, et al. (+2)
14 [GO] Molecular Pharmacology 2020―Oct―21 Dysregulation of ACE2 Expression and Function in Co-morbid Disease Conditions Possibly Contributes to COVID-19 Complication Severity Safaa Hammoud, Zena Wehbe, Samar Abdelhady, Firas Kobeissy, Ali Hussein Eid, Ahmed F El-Yazbi
15 [GO] Journal of Pharmacology and Experimental Therapeutics 2020―Oct―08 The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19 Ali Ehsan Sifat, Saeideh Nozohouri, Heidi Villalba, Bhuvaneshwar Vaidya, Thomas J. Abbruscato
16 [GO] Journal of Pharmacology and Experimental Therapeutics 2020―Oct―02 Role of GILZ in the Kidney and the Cardiovascular System: Relevance to Cardiorenal Complications of COVID-19 Mahmood Mozaffari
17 [GO] Molecular Pharmacology 2020―Sep―10 Heparin-binding peptides as novel therapies to stop SARS-CoV-2 cellular entry and infection Omid Tavassoly, Farinaz Safavi, Iman Tavassoly
18 [GO] Journal of Pharmacology and Experimental Therapeutics 2020―Jul―29 Drug discovery strategies for SARS-CoV-2 Zeenat A Shyr, Kirill Gorshkov, Catherine Z Chen, Wei Zheng
 [1] 

18 Results       Page 1




[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.008 sec